SOLIFENACIN ACCORD
5MG TBL FLM 100
SÚKL code | 0204027 |
---|---|
Name of the product | SOLIFENACIN ACCORD 5 MG POTAHOVANÉ TABLETY |
_MA_MEDICATION_DETAIL_INFO_MED_NAME i | SOLIFENACIN ACCORD |
Supplement | 5MG TBL FLM 100 |
Strenght | 5MG |
Pharmaceutical form | Film-coated tablet |
Package | 100 |
Route | Oral use |
Language of the pack | Czech |
Wrap type | Blister |
Legal status | na lékařský předpis |
Active substance | SOLIFENACIN SUCCINATE (SOLIFENACINI SUCCINAS) |
ATC group | G04BD08 |
ATC group name | SOLIFENACIN |
Marketing authorisation information
Registration Number | 73/ 173/15-C |
---|---|
Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
Placed on the market till | 30. 09. 2019 |
MA Holder | Accord Healthcare Limited, North Harrow |
MA Holder country | VELKÁ BRITÁNIE |
Actual MA holder | ACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava |
Actual MA holder country | POLSKO |